Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Osaki (Kobe, Japan), R. Tachikawa (Kobe, Japan), Y. Shima (Kobe, Japan), Y. Shimada (Kobe, Japan), A. Matsunashi (Kobe, Japan), K. Hosoya (Kobe, Japan), R. Hirabayashi (Kobe, Japan), Y. Sato (Kobe, Japan), K. Nagata (Kobe, Japan), A. Nakagawa (Kobe, Japan), K. Tomii (Kobe, Japan). Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates. 2746

Member's Comments

No comment yet.

Related content which might interest you: The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006 Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004 Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome Source: Eur Respir J 2004; 23: 142-145 Year: 2004 Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Prognostic significance of serum markers in acute exacerbation of idiopathic interstitial pneumonias Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Serum KL-6 and SP-D as useful clinical indicators of interstitial changes and pulmonary functional abnormality in patients with Sjogren's syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Diagnostic value of cystatin-C in pleural effusions associated with renal failure Source: Eur Respir J 2001; 18: Suppl. 33, 320s Year: 2001 Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure Source: Annual Congress 2008 - Pleural effusion Year: 2008 Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia Source: International Congress 2016 – Orphan diseases II Year: 2016 Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006 Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Usefulness of procalcitonin as a marker of bacterial inflammation in patients with heart failure and suspected pneumonia in x-ray examination Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD: human studies Year: 2011 Elevated levels of serum SP-A in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001